Abstract
Rationale
Chronic treatment with selective serotonin reuptake inhibitors (SSRIs) can delay ejaculation in humans, but the extent of this effect differs between SSRIs. The involvement of 5-HT1A receptors is likely, since 5-HT1A receptor agonists accelerate ejaculation and chronic SSRI treatment is thought to desensitize 5-HT1A receptors.
Objectives
This study was conducted to examine the effects of chronic pretreatment with the SSRIs fluvoxamine and paroxetine on the facilitation of ejaculation induced by the 5-HT1A receptor agonist 8-OH-DPAT.
Methods
Sexually experienced Wistar rats with normal ejaculatory behavior were treated for 22 days with vehicle, fluvoxamine (30 mg/kg/day), or paroxetine (10 or 20 mg/kg/day, p.o.). On day 22, rats received a challenge with saline or 8-OH-DPAT (0.4 mg/kg, s.c.). Sexual behavior was tested on days 1, 8, 15, and 22 of the SSRI-treatment.
Results
Treatment with both doses of paroxetine, but not fluvoxamine, delayed ejaculation. 8-OH-DPAT strongly accelerated ejaculation under vehicle conditions. Pretreatment with paroxetine reduced the effects of 8-OH-DPAT on ejaculation in a dose-dependent manner and more strongly than fluvoxamine.
Conclusions
SSRIs affect 5-HT1A receptors involved in ejaculation. The degree to which this occurs, with paroxetine exerting a stronger effect than fluvoxamine, might determine the extent of SSRI-induced delayed ejaculation.
Similar content being viewed by others
References
Ahlenius S, Larsson K (1997) Specific involvement of central 5-HT1A receptors in the mediation of male rat ejaculatory behavior. Neurochem Res 22:1065–1070
Ahlenius S, Larsson K (1998) Evidence for an involvement of 5-HT1B receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP. Psychopharmacology (Berl) 137:374–382
Ahlenius S, Larsson K (1999) Synergistic actions of the 5-HT1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior. Eur J Pharmacol 379:1–6
Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wikstrom H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL (1981) Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav 15:785–792
Argiolas A, Melis MR (2004) The role of oxytocin and the paraventricular nucleus in the sexual behaviour of male mammals. Physiol Behav 83:309–317
Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL (1993) Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem 268:23422–23426
Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152
Bosker FJ, Klompmakers AA, Westenberg HG (1995a) Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology 34:501–508
Bosker FJ, van Esseveldt KE, Klompmakers AA, Westenberg HG (1995b) Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology (Berl) 117:358–363
Cantor JM, Binik YM, Pfaus JG (1999) Chronic fluoxetine inhibits sexual behavior in the male rat: reversal with oxytocin. Psychopharmacology (Berl) 144:355–362
Coolen LM, Olivier B, Peters HJ, Veening JG (1997) Demonstration of ejaculation-induced neural activity in the male rat brain using 5-HT1A agonist 8-OH-DPAT. Physiol Behav 62:881–891
Davidson C, Stamford JA (1998) Contrasting effects of chronic paroxetine on 5-HT1A control of dorsal raphe cell firing and 5-HT release. NeuroReport 9:2535–2538
D’Souza DN, Zhang Y, Garcia F, Battaglia G, Van De Kar LD (2002) Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors. Psychopharmacology (Berl) 164:392–400
Fernandez-Guasti A, Escalante A (1991) Role of presynaptic serotonergic receptors on the mechanism of action of 5-HT1A and 5-HT1B agonists on masculine sexual behaviour: physiological and pharmacological implications. J Neural Transm Gen Sect 85:95–107
Fernandez-Guasti A, Rodriguez-Manzo G (1992) Further evidence showing that the inhibitory action of serotonin on rat masculine sexual behavior is mediated after the stimulation of 5-HT1B receptors. Pharmacol Biochem Behav 42:529–533
Fernandez-Guasti A, Escalante AL, Ahlenius S, Hillegaart V, Larsson K (1992) Stimulation of 5-HT1A and 5-HT1B receptors in brain regions and its effects on male rat sexual behaviour. Eur J Pharmacol 210:121–129
Foreman MM, Hall JL, Love RL (1989) The role of the 5-HT2 receptor in the regulation of sexual performance of male rats. Life Sci 45:1263–1270
Haensel SM, Slob AK (1997) Flesinoxan: a prosexual drug for male rats. Eur J Pharmacol 330:1–9
Hensler JG (2003) Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci 72:1665–1682
Hiemke C, Hartter S (2000) Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 85:11–28
Hillegaart V, Ahlenius S (1998) Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181. Br J Pharmacol 125:1733–1743
Kantor S, Graf M, Anheuer ZE, Bagdy G (2001) Rapid desensitization of 5-HT(1A) receptors in fawn-hooded rats after chronic fluoxetine treatment. Eur Neuropsychopharmacol 11:15–24
Klint T, Dahlgren IL, Larsson K (1992) The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior. Eur J Pharmacol 212:241–246
Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L (1995) Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol 352:141–148
Le Poul E, Boni C, Hanoun N, Laporte AM, Laaris N, Chauveau J, Hamon M, Lanfumey L (2000) Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39:110–122
Li Q, Muma NA, Battaglia G, Van de Kar LD (1997) A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors. J Pharmacol Exp Ther 282:1581–1590
Malagie I, Deslandes A, Gardier AM (2000) Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. Eur J Pharmacol 403:55–65
Matuszewich L, Lorrain DS, Trujillo R, Dominguez J, Putnam SK, Hull EM (1999) Partial antagonism of 8-OH-DPAT’S effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist. Brain Res 820:55–62
Maurel S, De Vry J, Schreiber R (1999) Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats. Alcohol 17:195–201
Neumaier JF, Sexton TJ, Yracheta J, Diaz AM, Brownfield M (2001) Localization of 5-HT(7) receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J Chem Neuroanat 21:63–73
Nutt DJ, Forshall S, Bell C, Rich A, Sandford J, Nash J, Argyropoulos S (1999) Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. Eur Neuropsychopharmacol 9(Suppl 3):S81–S86
Raap DK, Evans S, Garcia F, Li Q, Muma NA, Wolf WA, Battaglia G, Van De Kar LD (1999) Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. J Pharmacol Exp Ther 288:98–106
Rehman J, Kaynan A, Christ G, Valcic M, Maayani S, Melman A (1999) Modification of sexual behavior of Long–Evans male rats by drugs acting on the 5-HT1A receptor. Brain Res 821:414–425
Rinken A, Ferre S, Terasmaa A, Owman C, Fuxe K (1999) Serotonergic agonists behave as partial agonists at the dopamine D2 receptor. NeuroReport 10:493–495
Rosen RC, Lane RM, Menza M (1999) Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 19:67–85
Sanchez C, Meier E (1997) Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology (Berl) 129:197–205
Uvnas-Moberg K, Bjokstrand E, Hillegaart V, Ahlenius S (1999) Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology (Berl) 142:95–101
Waldinger MD (2004) Lifelong premature ejaculation: from authority-based to evidence-based medicine. BJU Int 93:201–207
Waldinger MD, Olivier B (1998) Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacol 13(Suppl 6):S27–S33
Waldinger MD, Berendsen HH, Blok BF, Olivier B, Holstege G (1998) Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 92:111–118
Waldinger MD, van De PA, Pattij T, van Oorschot R, Coolen LM, Veening JG, Olivier B (2002) The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology (Berl) 160:283–289
Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B (2004) Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 16:381–396
Watson NV, Gorzalka BB (1991) DOI-induced inhibition of copulatory behavior in male rats: reversal by 5-HT2 antagonists. Pharmacol Biochem Behav 39:605–612
Acknowledgements
This study was supported by an educational grant from Solvay Pharmaceuticals (Hannover, Germany). We thank Jos Dederen for his excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Jong, T.R., Pattij, T., Veening, J.G. et al. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine. Psychopharmacology 179, 509–515 (2005). https://doi.org/10.1007/s00213-005-2186-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-005-2186-6